[Inflammation and infection in stable coronary disease and acute coronary syndrome]

J Bermejo García1, P Martínez Martínez, J F Martín Rodríguez

  • 1Departamentos de Cardiología, ICICOR de la Universidad, Valladolid. jbgarcia@scisquemica.org

Insights

Inflammation is present in acute coronary syndromes, but serological tests do not link infection to coronary artery disease. Further research is needed to understand the causes of this inflammatory response.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Immunology

Background:

  • Coronary artery disease (CAD) is a leading cause of mortality worldwide.
  • The role of inflammation and infection in the development of CAD remains an area of active research.
  • Previous studies have suggested potential links between specific pathogens and CAD, but findings have been inconsistent.

Purpose of the Study:

  • To investigate the relationship between inflammation and infection in patients with acute and stable coronary artery disease.
  • To assess the prevalence of IgG and IgM antibodies against Chlamydia pneumoniae, Cytomegalovirus, and Helicobacter pylori in CAD patients and controls.
  • To evaluate C-reactive protein levels as a marker of inflammation in different CAD subgroups.

Main Methods:

  • A case-control study was conducted with 60 patients with acute coronary syndrome, 40 with stable CAD, and 40 healthy controls.
  • Serum samples were analyzed for IgG and IgM antibodies against C. pneumoniae, Cytomegalovirus, and H. pylori.
  • C-reactive protein (CRP) levels were measured in all participants, with serial CRP measurements in the acute coronary syndrome group.

Main Results:

  • No significant differences in IgG seropositivity for C. pneumoniae, Cytomegalovirus, or H. pylori were found among the acute, stable, and control groups.
  • A high prevalence of C-reactive protein positivity was observed in the acute coronary syndrome group (80%) compared to the stable CAD group (25%) and controls (0%).
  • CRP levels were significantly higher in Q-wave myocardial infarction than in unstable angina/non-Q-wave myocardial infarction and decreased one month after the acute event.

Conclusions:

  • Inflammation, as indicated by C-reactive protein, is significantly elevated in acute coronary syndromes and to a lesser extent in stable CAD.
  • Serological evidence does not support a direct link between C. pneumoniae, Cytomegalovirus, or H. pylori infection and the development of coronary syndromes.
  • The inflammatory response in CAD may be driven by mechanisms other than the infections assessed, suggesting serological methods may be inadequate for establishing such relationships.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...